K-MBSS Family
Request Consultation
ABOUT K-MBSS

What is K-MBSS? Korea Medical Business Smart Solution

A global healthcare network business platform based on the integration and convergence of medical technology and services.

K-MBSS

Background

Increasing Market

The increasing demand for international healthcare services and the growth of the international medical tourism market.

Collaborative System

The demand for innovation in patient care services and improved quality of medical treatment through a pre-surgery and surgical (remote) collaborative medical system and the sharing of medical expertise.

Sharing Technology

The need for international medical knowledge and technology sharing and an international medical network through an international healthcare expert exchange program.

Business Expansion

The sharing of global medical research, technology and equipment information, and business expansion through distribution of new treatment methods and medical technology.

NK GLOBAL HOLDINGS CO., LTD.

Medical · Beauty · Healthcare Business Platform

WHO WE ARE

Licensing, distribution, education and services — the entire path into Indonesia in one value chain.

NK Global Holdings (Seoul, est. March 2020) and its Indonesian subsidiary PT Korea Medibiz Platform (Jakarta, est. June 2024, 100% foreign-owned PMA) operate as one integrated organization under the K-MBSS brand.

Our Korea headquarters leads global planning, sourcing, R&D and content development with Korean government, hospital and university partners. PT KMP runs local licensing and regulatory affairs, marketing and sales, working with the Indonesian Ministry of Health, medical societies and key opinion leaders.

01 · ENTRYEntry Solution Platform

One-stop market entry infrastructure — local licensing (IDAK · BPOM · AKL), distribution and business development.

02 · DISTRIBUTIONSales & Distribution Value Chain

Curated Korean medical devices and beauty products, delivered through online and offline omni-channel marketing.

03 · DIGITALDigital & AI Ecosystem

Digital and subscription business models, including medical AI diagnostics, built on top of our offline network.

4 PLATFORMS

One partner, one contract — four platforms, each answering one barrier to entering Indonesia.

CertificationCDAKB · BPOM · AKL licensing through our own local PMA
Service · Mediakmedibiz.com B2B platform, HCP webinars, TV partnership (TIC) and MICE
EducationHands-on and cadaver workshops and academic seminars with Korean KOLs
DistributionClinic sales network, Roxy K-PharmaCare Zone and medical AI solutions

20+ registered products · 1,300+ aesthetic doctors · 45 Roxy outlets · 38 Poltekkes · 4 online platforms

2020 – 2026

OUR HISTORY

  1. 01Foundation

    Early business footing and growth engine

    Responded quickly to the pandemic to secure early survival and the capabilities for global expansion

    1. NK Global Holdings established in Seoul
    2. Launched NK 3S solution (SWTB) business
    3. SWTB cooperative project with Catholic Kwandong University International St. Mary's Hospital
    Highlights
    • Export of COVID-19 test kits and infection-control supplies
    • Operation of COVID-19 testing centres
    • Regulatory sandbox approval for overseas telemedicine
  2. 02New-business preparation

    Entry strategy and early business infrastructure

    In-depth research on the Indonesian healthcare market and a network with the Ministry of Health (MOH) and key KOLs

    1. K-MBSS platform launched and first K-MBSS forum held
    2. Launched healthcare brand "Dr.K24"
    3. Launched K-MBST, a medical representative academy training program
    4. K-MBSS trademark registered (KIPO No. 40-2164938, Class 44 medical information services, etc.)
    5. FILL;YOU trademark registered (KIPO No. 40-2198582, Class 5 medical fillers, etc.)
    Highlights
    • Corporate R&D centre and advisory board formed
    • Partnership with Korea–Indonesia medical associations and PERDAWERI
  3. 03Launch

    Business foundation completed and full launch

    Local entity, core licences and permits, and an own brand put in place, followed by entry into government programmes

    1. PT Korea Medibiz Platform established in Jakarta (100% foreign-owned PMA)
    2. 15+ medical device and cosmetic licenses (CDAKB · BPOM · AKL), B2B platform launch
    3. Exclusive Korea partner of the Kemenkes International Fellowship Program
    Highlights
    • Core business licences obtained
  4. 04Growth accelerationNow

    Full-scale expansion and platform completion

    Concentrated investment in the secured distribution network and a shift to digital platforms to drive revenue and enterprise value

    1. MOUs with Roxy Group, The Indonesia Channel (TIC) and EDU Leaderboard
    2. K-MBSS Academy Clinic opened (Felicity Skin Clinic, Jakarta)
    Next steps
    • Marketing and sales built on offline infrastructure
    • Government public tenders
    • AI diagnostics and B2B commerce digital ecosystem
    • B2B/B2C online distribution platform launch
    • Edutech platform launch
LICENCES

Licences & Certifications

Trademark certificates

Licences & permits

  • PT KMP – 8 Registered KBLI Codes
  • PT KMP – NIB Business Identification Number
  • PT KMP – PMA Foreign Investment Approval
  • PT KMP – IDAK Medical Device Distribution License
  • PT KMP – CDAKB Good Distribution Practice
  • PT KMP – BPOM Cosmetics Importer
  • PT KMP – KBLI 86105 Private Primary Clinic
  • PT KMP – KBLI 86903 Health Support Services
  • PT KMP – KBLI 85494 Private Health Education
  • PT KMP – KBLI 82302 Event Organizing
  • K-MBSS Registered Trademark (KIPO)
  • FILL;YOU Registered Trademark (KIPO)
  • Foreign Patient Attraction Business Registration
  • Tourism Business Registration
  • Corporate R&D Center Certificate
  • ICT Regulatory Sandbox Designation
  • Business Registration Certificate
  • Medical Device Sales Business Report
  • Guarantee Insurance Certificate
  • Guarantee Insurance Certificate (Amended)

Ready to enter the Indonesian market?

Licensing, distribution, education and marketing - one partner, one contract.